Annual CFI
-$471.70 K
+$2.09 M+81.60%
30 September 2022
Summary:
NeuBase Therapeutics annual cash flow from investing activities is currently -$471.70 thousand, with the most recent change of +$2.09 million (+81.60%) on 30 September 2022. During the last 3 years, it has risen by +$2.09 million (+81.60%).NBSE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 September 2023
Summary:
NeuBase Therapeutics quarterly cash flow from investing activities is currently $0.00, unchanged on 30 September 2023.NBSE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$54.70 K
+$28.80 K+34.49%
30 September 2023
Summary:
NeuBase Therapeutics TTM cash flow from investing activities is currently -$54.70 thousand, with the most recent change of +$28.80 thousand (+34.49%) on 30 September 2023.NBSE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +81.6% | +100.0% | +97.9% |
| 5 y5 years | +31.2% | +100.0% | +92.0% |
NBSE Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -189.3% | -100.0% | -110.4% |
NeuBase Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $0.00(0.0%) | -$54.70 K(-34.5%) |
| June 2023 | - | $0.00(-100.0%) | -$83.50 K(-67.1%) |
| Mar 2023 | - | -$4900.00(-90.2%) | -$254.10 K(-36.1%) |
| Dec 2022 | - | -$49.80 K(+72.9%) | -$397.60 K(-15.7%) |
| Sept 2022 | -$471.70 K(-81.6%) | -$28.80 K(-83.1%) | -$471.70 K(-40.6%) |
| June 2022 | - | -$170.60 K(+15.0%) | -$794.50 K(-67.1%) |
| Mar 2022 | - | -$148.40 K(+19.8%) | -$2.42 M(-2.5%) |
| Dec 2021 | - | -$123.90 K(-64.8%) | -$2.48 M(-3.3%) |
| Sept 2021 | -$2.56 M(+257.6%) | -$351.60 K(-80.4%) | -$2.56 M(-0.1%) |
| June 2021 | - | -$1.79 M(+756.7%) | -$2.57 M(+163.7%) |
| Mar 2021 | - | -$209.40 K(+0.4%) | -$972.80 K(+13.5%) |
| Dec 2020 | - | -$208.50 K(-41.1%) | -$856.90 K(+19.5%) |
| Sept 2020 | -$716.80 K(+4.6%) | -$353.90 K(+76.1%) | -$716.80 K(-31.3%) |
| June 2020 | - | -$201.00 K(+115.0%) | -$1.04 M(+23.8%) |
| Mar 2020 | - | -$93.50 K(+36.7%) | -$843.10 K(+11.9%) |
| Dec 2019 | - | -$68.40 K(-90.0%) | -$753.70 K(+10.0%) |
| Sept 2019 | -$685.20 K(-229.8%) | -$681.20 K(<-9900.0%) | -$685.30 K(-4410.1%) |
| June 2019 | - | $0.00(-100.0%) | $15.90 K(-97.0%) |
| Mar 2019 | - | -$4100.00(-120.5%) | $524.00 K(-0.8%) |
| Sept 2018 | $528.00 K(+496.6%) | $20.00 K(-96.1%) | $528.10 K(+2.9%) |
| June 2018 | - | $508.10 K(>+9900.0%) | $513.10 K(+449.9%) |
| Mar 2018 | - | $0.00(-100.0%) | $93.30 K(+5.4%) |
| Sept 2017 | $88.50 K(-710.3%) | $5000.00(-94.3%) | $88.50 K(+7.5%) |
| June 2017 | - | $88.30 K(>+9900.0%) | $82.30 K(-1243.1%) |
| Mar 2017 | - | $0.00(-100.0%) | -$7200.00(-18.2%) |
| Dec 2016 | - | -$4800.00(+300.0%) | -$8800.00(-39.7%) |
| Sept 2016 | -$14.50 K(-94.9%) | -$1200.00(0.0%) | -$14.60 K(-5.8%) |
| June 2016 | - | -$1200.00(-25.0%) | -$15.50 K(-85.9%) |
| Mar 2016 | - | -$1600.00(-84.9%) | -$110.30 K(-62.7%) |
| Dec 2015 | - | -$10.60 K(+404.8%) | -$295.60 K(+3.7%) |
| Sept 2015 | -$285.00 K(-91.9%) | -$2100.00(-97.8%) | -$285.00 K(-4.3%) |
| June 2015 | - | -$96.00 K(-48.6%) | -$297.80 K(-92.0%) |
| Mar 2015 | - | -$186.90 K(<-9900.0%) | -$3.70 M(+5.3%) |
| Dec 2014 | - | $0.00(-100.0%) | -$3.51 M(0.0%) |
| Sept 2014 | -$3.51 M | -$14.90 K(-99.6%) | -$3.51 M(+0.4%) |
| June 2014 | - | -$3.50 M(<-9900.0%) | -$3.50 M(<-9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2012 | -$33.40 K(-147.4%) | $0.00(0.0%) | -$33.40 K(0.0%) |
| June 2012 | - | $0.00(0.0%) | -$33.40 K(0.0%) |
| Mar 2012 | - | $0.00(-100.0%) | -$33.40 K(-190.0%) |
| Dec 2011 | - | -$33.40 K(<-9900.0%) | $37.10 K(-47.4%) |
| Sept 2011 | $70.50 K(-382.0%) | $0.00(0.0%) | $70.50 K(+54.9%) |
| June 2011 | - | $0.00(-100.0%) | $45.50 K(0.0%) |
| Mar 2011 | - | $70.50 K(>+9900.0%) | $45.50 K(-282.0%) |
| Dec 2010 | - | $0.00(-100.0%) | -$25.00 K(0.0%) |
| Sept 2010 | -$25.00 K(-91.7%) | -$25.00 K(<-9900.0%) | -$25.00 K(-87.0%) |
| June 2010 | - | $0.00(0.0%) | -$192.00 K(0.0%) |
| Mar 2010 | - | $0.00(-100.0%) | -$192.00 K(-36.0%) |
| Sept 2009 | -$300.00 K(-171.8%) | -$192.00 K(<-9900.0%) | -$300.00 K(+100.0%) |
| June 2009 | - | $0.00(-100.0%) | -$150.00 K(0.0%) |
| Mar 2009 | - | -$108.00 K(+157.1%) | -$150.00 K(-135.9%) |
| Sept 2008 | $418.00 K(-210.0%) | -$42.00 K(<-9900.0%) | $418.00 K(-9.1%) |
| June 2008 | - | $0.00(0.0%) | $460.00 K(0.0%) |
| Mar 2008 | - | $0.00(-100.0%) | $460.00 K(0.0%) |
| Dec 2007 | - | $460.00 K(>+9900.0%) | $460.00 K(-207.7%) |
| Sept 2007 | -$380.00 K(-11.0%) | - | - |
| June 2006 | - | $2900.00(-200.0%) | -$427.20 K(+25.0%) |
| Mar 2006 | - | -$2900.00(-96.2%) | -$341.80 K(-20.0%) |
| Dec 2005 | -$427.20 K(-299.3%) | -$77.20 K(-77.9%) | -$427.20 K(+7020.0%) |
| Sept 2005 | - | -$350.00 K(-496.4%) | -$6000.00(-102.3%) |
| June 2005 | - | $88.30 K(-200.0%) | $260.90 K(+56.3%) |
| Mar 2005 | - | -$88.30 K(-125.7%) | $166.90 K(-22.1%) |
| Dec 2004 | $214.30 K(-173.4%) | $344.00 K(-514.0%) | $214.30 K(-265.2%) |
| Sept 2004 | - | -$83.10 K(+1357.9%) | -$129.70 K(+178.3%) |
| June 2004 | - | -$5700.00(-86.1%) | -$46.60 K(+13.9%) |
| Mar 2004 | - | -$40.90 K | -$40.90 K |
| Dec 2003 | -$291.80 K | - | - |
FAQ
- What is NeuBase Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for NeuBase Therapeutics?
- What is NeuBase Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for NeuBase Therapeutics?
What is NeuBase Therapeutics annual cash flow from investing activities?
The current annual CFI of NBSE is -$471.70 K
What is the all time high annual CFI for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual cash flow from investing activities is $528.00 K
What is NeuBase Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of NBSE is $0.00
What is the all time high quarterly CFI for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly cash flow from investing activities is $508.10 K
What is NeuBase Therapeutics TTM cash flow from investing activities?
The current TTM CFI of NBSE is -$54.70 K
What is the all time high TTM CFI for NeuBase Therapeutics?
NeuBase Therapeutics all-time high TTM cash flow from investing activities is $528.10 K